Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

TGF-β Superfamily Conference: Signaling in Development and Disease

Award Number: R13CA290999
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

TGF-β Superfamily Conference: Signaling in Development and Disease - Abstract The FASEB SRC TGF-β Superfamily: Signaling in Development and Disease Conference in 2024 (hereafter “TGF-β 2024”) will bring together investigators who are leaders in a variety of interconnected and interrelated disciplines that intersect through a key role of TGF-β signaling in the process. Bringing together such a diverse group of scientists is essential for a comprehensive understanding and assessment of the TGF-β signaling axis in development, homeostasis, regeneration, aging, injury, and disease. The scientific presentations, formal and informal discussions, and poster presentations throughout the conference are designed to expand the understanding of the genetic, molecular and cellular mechanisms and processes by which the TGF-β signaling axis influences development and maintenance of organ systems, and to uncover how deregulation of this control results in disease. This knowledge is fundamental to understand how TGF-β signaling pathways are regulated and how they execute their functions under normal conditions in restoring the homeostasis of the body and facilitating successful tissue repair and regeneration. TGF-β 2021 will leverage new and important findings and provide attendees with: a broader appreciation and perspective of the complexity of the TGF-β signaling axis; examples of therapeutic strategies being tested and opportunities for considering and discussing future ones. This is the 13th FASEB TGF-β conference. The field of TGF-β signaling has been rapidly advancing and expanding; in particular, almost 10,000 articles per year related to TGF-β/BMP/GDF/Activin/Nodal have been published in the past five years. This fast pace warrants the convening of this conference and ensures its success. TGF-β 2024 takes pride in the strong tradition of collegiality of conference attendees and, most importantly, the collaborations that are generated through this conference. The collective experience built over the previous twelve conferences has provided us with the confidence that TGF-β 2024 provides a forum for extended discussions and conversations, interactions, networking, debating of novel hypotheses and prioritization of unmet research or therapeutic needs, and career training/advice particularly for young investigators and trainees from diverse backgrounds who represent future researchers in this field.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$10 )
2026	2024	FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY	6120 EXECUTIVE BLVD STE 230	ROCKVILLE	MD	20852	MONTGOMERY	USA	Cancer Research Manpower	000	1	11/28/2025	NEW	-$10
														Subtotal = -$10

Issue Date FY: 2024 ( Subtotal = $20,000 )
2024	2024	FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY	6120 EXECUTIVE BLVD STE 575	ROCKVILLE	MD	20852	MONTGOMERY	USA	Cancer Research Manpower	000	1	4/16/2024	NEW	$20,000
														Subtotal = $20,000

Grand Total All Awards = $19,990

Top

All Categories

About

Search

Reports

Data Submission

Award Information

TGF-β Superfamily Conference: Signaling in Development and Disease

Award Number: R13CA290999

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer